EPs 7630 in adults and children with acute tonsillitis;EPs 7630 bei erwachsenen und kindern mit angina tonsillaris

Zeitschrift fur Phytotherapie

Volumn 30, Issue 1, 2009, Pages 6-12

  Bereznoj, V V ^a   Heger, M ^b   Iljenko, L J ^c   Tischko, F A ^d  

^a Gesundheitsministerium der Ukraine   (Ukraine)

^b ISO Arzneimittel   (Germany)

^c Russ Staatl Univ   (Russian Federation)

^d Lehrstuhl f HNO Heilkunde   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PELARGONIUM SIDOIDES EXTRACT;

ABSCESS; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHYTOTHERAPY; PRESCHOOL CHILD; REMISSION; SCHOOL CHILD; TONSILLITIS; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 73549110683     PISSN: 0722348X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1213421     Document Type: Article

References (18)

1. Arzneimittelkommission der Deutschen Ärzteschaft. Therapieempfehlungen der Arzneimittelkommission der Deutschen Ärzteschaft. Akute Atemwegsinfektionen. Köln: Deutscher Ärzte-Verlag; 2002: 17-22
2. Bachert C, Schapowal A, Funk P, Kieser M. Treatment of acute rhinosinusitis with the preparation from Pelargonium sidoides EPs 7630: A randomized, double-blind, placebo-controlled trial. Rhinology 2009 (im Druck)
3. Bladt S, Wagner H. From the Zulu medicine to the European phytomedicine Umckaloabo®. Phytomedicine 2007; 14 (Suppl VI): 2-4
4. Blochin B, Heger M. Umckaloabo versus symptomatische Therapie in der Behandlung der akuten Angina Catarrhalis. Päd 2000; 6: 2-8
5. Chuchalin AG, Berman B, Lehmacher W. Treatment of acute bronchitis in adults with a Pelargonium sidoides preparation (EPs® 7630): A randomized, double-blind, placebo-controlled trial. Explore 2005; 1: 437-445
6. Conrad A, Hansmann C, Engels I et al. Extract of Pelargonium sidoides (EPs® 7630) improves phagocytosis, oxidative burst, and intracellular killing of human peripheral blood phagocytes in vitro. Phytomedicine 2007; 14 (Suppl. VI): 46-51
7. Dome L, Schuster R. Umckaloabo - eine phytotherapeutische Alternative bei akuter Bronchitis im Kindesalter? Ärztez Naturheilverf 1996; 37: 216-222
8. Haidvogl M, Heger M. Treatment effect and safety of EPs® 7630-solution in acute bronchitis in childhood: Report of a multicentre observational study. Phytomedicine 2007; 14 (Suppl VI): 60-64 (Pubitemid 46209769)
9. Katić M, Katić V, Ivanković D et al. General practitioners' patterns of antimicrobial drugs prescription in the therapy of acute pharyngitis. Scand J Prim Health Care 2000; 18: 30-34
10. Kolodziej H, Kiderlen AF. In vitro evaluation of antibacterial and immunomodulatory activities of Pelargonium reniforme, Pelargonium sidoides and the related herbal drug preparation EPs® 7630. Phytomedicine 2007; 14 (Suppl VI): 18-26
11. Kolodziej H. Fascinating metabolic pools of Pelargonium sidoides and Pelargonium reniforme, traditional and phytomedicinal sources of the herbal medicine Umckaloabo®. Phytomedicine 2007; 14 (Suppl VI): 9-17 (Pubitemid 46209773)
12. Kolodziej H, Kayser O, Radtke OA et al. Pharmacological profile of extracts of Pelargonium sidoides and their constituents. Phytomedicine 2003; 10 (Suppl IV): 18-24 (Pubitemid 36597152)
13. Matthys H, Funk P. EPs 7630 improves acute bronchitis symptoms and shortens time to remission. Results of a randomised, double-blind, placebo-controlled, multicentre trial. Planta Med 2008; 74: 686-692
14. Matthys H, Heger M. Treatment of acute bronchitis with a liquid herbal drug preparation from Pelargonium sidoides (EPs 7630): a randomised, double-blind, placebo-controlled, multicentre study. Curr Med Res Opin 2007; 23: 323-331 (Pubitemid 46333381)
15. Paluck E, Katzenstein D, Frankish CJ et al. Prescribing practices and attitudes toward giving children antibiotics. Can Fam Physician 2001; 47: 521-527
16. Schapowal A, Heger M. EPs® 7630 Lösung (Umckaloabo®) bei Sinusitis. Z Phytother 2007; 28: 58-65 (Pubitemid 47234165)
17. Stucki G. Outcome-Meßinstrumente zur Beurteilung der klinischen Ergebnisqualität. Akt Rheumatol 1997; 22 (Suppl 1): S3-S5
18. Wegener T, Schneider B, Arbeitsgruppe »Klinische Prüfung pflanzlicher Arzneimittel« der Gesellschaft für Phytotherapie. Maßnahmen zur Verbesserung der Qualität von Anwendungsbeobachtungen. Z Phytother 2003; 24: 233-240